2006 Press Releases

ImmuneRegen Begins Next Study With Oak Ridge National Laboratory (ORNL)
Aug. 31, 2006

ImmuneRegen Announces Further Results From Anthrax Treatment Study
Aug. 17, 2006

ImmuneRegen Product to be Tested as Defense to Potential Biological Weapon
Aug. 2, 2006

Singapore's DSO National Laboratories to Study ImmuneRegen's Viprovex(TM)
July 31, 2006

NIH to Conduct Preclinical Evaluation of ImmuneRegen's Radilex(TM)
July 24, 2006

ImmuneRegen BioSciences, Inc. Appoints Investor Awareness, Inc. to Launch Investor Relations Program
July 18, 2006

NIH to Conduct Anti-Microbial Evaluation of ImmuneRegen's Viprovex(TM)
June 28, 2006

ImmuneRegen Announces Additional Rounds of Testing in Anthrax Treatment Study
June 20, 2006

ImmuneRegen BioSciences and Oak Ridge National Laboratory Announce Initial Results From Radilex(TM) Testing
June 1, 2006

ImmuneRegen BioSciences Plans Response to Upcoming Department of Health and Human Services RFP for Advanced Development of New Antiviral Agents for Influenza
May 31, 2006

ImmuneRegen BioSciences Appoints Kelly McQueen to Advisory Board
March 6, 2006

ImmuneRegen BioSciences Submits Response to Department of Defense for Sources Sought Notice
February 6, 2006

ImmuneRegen BioSciences Appoints James Robert Campbell, Ph.D., to Bioterrorism Preparedness Advisory Board
January 26, 2006

ImmuneRegen BioSciences Responds to Department of Defense
January 17, 2006

ImmuneRegen BioSciences Appoints Asa Hutchinson to Bioterrorism Preparedness Advisory Board
January 6, 2006

 

 

Copyright © 2003-2008, ImmuneRegen Biosciences, Inc. All rights reserved.

News Archives

Press releases and news articles from

2007 >>

2006 >>

2005 >>

2004 >>